Lv41
700 积分 2023-08-03 加入
[Guidelines for diagnosis and treatment of advanced breast cancer in China (2024 edition)]
3小时前
待确认
[Guidelines on tests of PIK3CA mutation in breast cancer in China (2025 version)]
3小时前
待确认
[Consensus on the molecular residual disease testing in solid tumor]
3个月前
已完结
Somatic copy number alterations predict response to platinum therapy in epithelial ovarian cancer
5个月前
已完结
AKT1 gene amplification as a biomarker of treatment response in ovarian cancer: Mounting evidence of a therapeutic target
5个月前
已完结
The next generation of PI3K-Akt-mTOR pathway inhibitors in breast cancer cohorts
6个月前
已完结
Impact of a centralized archive for pathology laboratories on the health system
6个月前
已完结
Cancer incidence and mortality in China, 2022
8个月前
已完结
Mechanisms of PTEN loss in cancer: It’s all about diversity
9个月前
已完结
Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities
11个月前
已完结
皖公网安备34019202002308
